Table 1.

Characteristics of the patients

	All (n = 253)	Normal blood glucose (n = 94)	Hyperglycemia (n = 159)	P
Age, years, median (range)	60 (37,83)	60 (37,80)	61 (38,83)	0.516
BMI, median (range)	23.3 (12.4,32.1)	22.3 (15.5,29)	23.5 (12.4,32.1)	0.039
Sex, n (%)				0.002
Female	106 (41.7%)	27 (28.7%)	79 (49.4%)
Male	148 (58.5%)	67 (71.3%)	81 (50.9%)
Smoking history, n (%)	93 (36.8%)	46 (48.9%)	47 (29.6%)	0.002
Drinking history, n (%)	49 (19.4%)	21 (22.3%)	28 (17.7%)	0.370
Diabetes history, n (%)	65 (25.7%)	7 (7.4%)	58 (36.5%)	< 0.001
Hypertension history, n (%)	70 (27.7%)	19 (20.2%)	51 (32.1%)	0.042
Allergic history, n (%)	33 (13%)	7 (7.4%)	26 (16.4%)	0.042
Abdominal pain, n (%)	174 (69.9%)	69 (74.2%)	105 (67.3%)	0.252
Back pain, n (%)	38 (15.3%)	17 (18.3%)	21 (13.5%)	0.306
Anorexia, n (%)	10 (4%)	2 (2.2%)	8 (5.1%)	0.329
Loss of appetite, n (%)	106 (42.6%)	37 (39.8%)	69 (44.2%)	0.493
Loss of weight, n (%)	154 (61.8%)	50 (53.8%)	104 (66.7%)	0.043
CA199, n (%)				0.383
Normal	51 (21.9%)	22 (24.7%)	29 (20.1%)
37–1000	147 (63.1%)	57 (64%)	90 (62.5%)
> 1000	35 (15%)	10 (11.2%)	25 (17.4%)
Surgical procedure, n (%)				0.932
Whipple	192 (75.9%)	73 (77.7%)	119 (74.8%)
Distal	52 (20.6%)	18 (19.1%)	34 (21.4%)
Other	9 (3.6%)	3 (3.2%)	6 (3.8%)
Site of onset, n (%)				0.790
Head of pancreas	201 (79.8%)	75 (80.6%)	126 (79.2%)
Tail of pancreas	51 (20.2%)	18 (19.4%)	33 (20.8%)
Differentiation, n (%)				0.613
Poor	61 (24.1%)	21 (22.3%)	40 (25.2%)
Moderate-high	192 (75.9%)	73 (77.7%)	119 (74.8%)
AJCC8 staging				0.677
Stage I	121 (47.8%)	48 (51.1%)	73 (45.9%)
Stage II	86 (34%)	31 (33%)	55 (34.6%)
Stage III-IV	46 (18.2%)	15 (16%)	31 (19.5%)
Obstructive jaundice	129 (51%)	44 (46.8%)	85 (53.5%)	0.307
Follow-up time, months, median (range)	16.5 (0.1,95)	20.9 (0.5,95)	14.2 (0.1,93.3)	0.327

BMI body mass index, CA cancer antigen, AJCC American Joint Committee on Cancer